Depth filtration for clarification of intensified lentiviral vector suspension cell culture

Author:

Mayani Mukesh12ORCID,Nellimarla Srinivas1,Mangalathillam Ratish3,Rao Hema1,Patarroyo‐White Susannah1,Ma Junfen1,Figueroa Bruno1

Affiliation:

1. Genomic Medicine Unit CMC, Global CMC Development Waltham Massachusetts USA

2. Process and Analytical Development (PAD), Gene Therapy Franchise, National Resilience Inc. Waltham Massachusetts USA

3. MilliporeSigma Burlington Massachusetts USA

Abstract

AbstractDepth filtration significantly impacts efficiency of lentiviral (LV) vector purification process. However, it is often deprioritized in the overall scope of viral vector manufacturing process optimization. The demand for LV vectors has increased with the rise in disease indications, making it crucial to improve current manufacturing processes. Upstream bioreactor process intensification has enabled cell densities of over 107 viable cells/mL, creating challenges for harvest unit operations. The larger size of LV vectors and their physiochemical similarity to host cell‐DNA (HC‐DNA) and poor clarification performance causes significant challenges for the subsequent chromatography‐based purifications. As a result, a robust and scalable harvest of LV process is needed, especially for LV in vivo therapeutic quality needs. In this study, we systematically evaluated the overlooked yet important issue of depth filtration systems to improve enveloped LV functional vector recovery. We found that an established depth filtration system in process A that provided 94% (n = 6) LV functional recovery could not be translated to intensified Process B cell culture. Hence, the depth filtration process became a bottleneck for the purification performance in an intensified process. We demonstrated an improvement in LV functional vector recovery from 34% to 82% via filter train optimization for an intensified suspension cell culture system (>107 cells/mL with higher titer), while still maintaining a loading throughput of ≥82 L/m2 and turbidity ≤20 NTU. It was demonstrated that the two or three‐stage depth filtration scheme is scalable and more suitable for high cell density culture for large scale for LV manufacturing process.

Publisher

Wiley

Subject

Biotechnology

Reference21 articles.

1. Food and Drug Administration.Approved cellular and gene therapy products. US Food & Drug Administration website available at:https://www.fda.gov/vaccines‐blood‐biologics/cellular‐gene‐therapy‐products/approved‐cellular‐and‐gene‐therapy‐products. Accessed January 07 2023

2. Global Manufacturing of CAR T Cell Therapy

3. Production of lentiviral vectors

4. Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3